Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.

Por Mora, J., Gascón, N., Tabernero, J. M., Rodríguez-Espinosa, J., González-Sastre, F.
Publicado em 1996

Pharmacokinetics of phosphomycin during haemofiltration.

Por Fernandez Lastra, C, Mariño, E L, Dominguez-Gil, A, Tabernero, J M, Grande Villoria, J
Publicado em 1984

Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer

Por Joulain, F, Proskorovsky, I, Allegra, C, Tabernero, J, Hoyle, M, Iqbal, S U, Van Cutsem, E
Publicado em 2013

Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines

Por Vilar, E, Scaltriti, M, Balmaña, J, Saura, C, Guzman, M, Arribas, J, Baselga, J, Tabernero, J
Publicado em 2008

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

Por Elez, E, Hendlisz, A, Delaunoit, T, Sastre, J, Cervantes, A, Varea, R, Chao, G, Wallin, J, Tabernero, J
Publicado no Br J Cancer (2016)

Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review

Por García-Foncillas, J, Alba, E, Aranda, E, Díaz-Rubio, E, López-López, R, Tabernero, J, Vivancos, A
Publicado no Ann Oncol (2017)

Randomized Phase 3 Study of Panitumumab With FOLFOX4 Compared to FOLFOX4 Alone as 1(st)-line Treatment (tx) for Metastatic Colorectal Cancer (mCRC): The PRIME Trial

Por Douillard, J.Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M.E., Humblet, Y., Cunningham, D., Wolf, M., Gansert, J.
Publicado em 2010

PD-024 Retrospective analysis of quality of life and early tumour shrinkage during first-line FOLFOX4 ± panitumumab in RAS wild-type metastatic colorectal carcinoma

Por Siena, S., Tabernero, J., Bodoky, G., Cunningham, D., Rivera, F., Ruff, P., Canon, J.-L., Koukakis, R., Demonty, G., Douillard, J.-Y.
Publicado no Ann Oncol (2016)

Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

Por Dienstmann, R., Rodon, J., Prat, A., Perez-Garcia, J., Adamo, B., Felip, E., Cortes, J., Iafrate, A. J., Nuciforo, P., Tabernero, J.
Publicado no Ann Oncol (2014)

PD-008 Adding ramucirumab to second-line irinotecan, 5-fluorouracil and folinic acid (FOLFIRI) treatment for metastatic colorectal carcinoma (mCRC): resource utilization data from...

Por Kisro, J., Cohn, A., Yoshino, T., Van Cutsem, E., Hegewisch-Becker, S., Kullmann, F., Brück, P., Liepa, A., Yang, L., Nasroulah, F., Tabernero, J.
Publicado no Ann Oncol (2016)

Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies

Por Boeckx, N., Koukakis, R., Op de Beeck, K., Rolfo, C., Van Camp, G., Siena, S., Tabernero, J., Douillard, J.-Y., André, T., Peeters, M.
Publicado no Ann Oncol (2017)

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

Por Macarulla, T, Cervantes, A, Tabernero, J, Roselló, S, Van Cutsem, E, Tejpar, S, Prenen, H, Martinelli, E, Troiani, T, Laffranchi, B, Jego, V, von Richter, O, Ciardiello, F
Publicado no Br J Cancer (2015)

PD-029 Baseline carcinoembryonic antigen (CEA) as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma (mCRC) phase 3 trial

Por Yoshino, T., Obermannová, R., Bodoky, G., Garcia-Carbonero, R., Ciuleanu, T.-E., Portnoy, D., Kim Tae, W., Hsu, Y., Yang, L., Ferry, D., Nasroulah, F., Tabernero, J.
Publicado no Ann Oncol (2016)

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: r...

Por Longo-Muñoz, F., Argiles, G., Tabernero, J., Cervantes, A., Gravalos, C., Pericay, C., Gil-Calle, S., Mizuguchi, H., Carrato-Mena, A., Limón, M. L., Garcia-Carbonero , R.
Publicado no Clin Transl Oncol (2016)

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six ran...

Por Arnold, D., Lueza, B., Douillard, J.-Y., Peeters, M., Lenz, H.-J., Venook, A., Heinemann, V., Van Cutsem, E., Pignon, J.-P., Tabernero, J., Cervantes, A., Ciardiello, F.
Publicado no Ann Oncol (2017)

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers

Por Cherny, N I, Sullivan, R, Dafni, U, Kerst, J M, Sobrero, A, Zielinski, C, Piccart, M J, Bogaerts, J, Tabernero, J, Latino, N J, de Vries, E G E
Publicado no ESMO Open (2016)

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer

Por Siena, S, Sartore-Bianchi, A, Garcia-Carbonero, R, Karthaus, M, Smith, D, Tabernero, J, Van Cutsem, E, Guan, X, Boedigheimer, M, Ang, A, Twomey, B, Bach, B A, Jung, A S, Bardelli, A
Publicado no Ann Oncol (2018)

Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial

Por Melichar, B, Casado, E, Bridgewater, J, Bennouna, J, Campone, M, Vitek, P, Delord, J-P, Cerman, J, Salazar, R, Dvorak, J, Sguotti, C, Urban, P, Viraswami-Appanna, K, Tan, E, Tabernero, J
Publicado em 2011

Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic a...

Por Ramanathan, R. K., Goldstein, D., Korn, R. L., Arena, F., Moore, M., Siena, S., Teixeira, L., Tabernero, J., Van Laethem, J.-L., Liu, H., McGovern, D., Lu, B., Von Hoff, D. D.
Publicado no Ann Oncol (2016)

Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metast...

Por Obermannová, R., Van Cutsem, E., Yoshino, T., Bodoky, G., Prausová, J., Garcia-Carbonero, R., Ciuleanu, T., Garcia Alfonso, P., Portnoy, D., Cohn, A., Yamazaki, K., Clingan, P., Lonardi, S., Kim, T. W., Yang, L., Nasroulah, F., Tabernero, J.
Publicado no Ann Oncol (2016)